Enzymatica publ AB (ST:ENZY) — Stock Price

Skr1.91 SEK
▲ 1.60% today

Enzymatica publ AB (ST:ENZY) is currently trading at Skr1.91 SEK, up 1.60% today. Over the past 52 weeks, shares have ranged between Skr1.65 and Skr3.20. This page tracks Enzymatica publ AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Enzymatica publ AB (ENZY) total market value.

Enzymatica publ AB (ENZY) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Enzymatica publ AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Enzymatica publ AB Income Statement — Revenue, Profit & Earnings by Year

Enzymatica publ AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Skr45.58 Million Skr50.90 Million Skr48.95 Million Skr57.24 Million Skr111.25 Million
Cost of Revenue Skr14.86 Million Skr19.04 Million Skr20.49 Million Skr23.89 Million Skr35.29 Million
Gross Profit Skr30.72 Million Skr31.86 Million Skr28.45 Million Skr33.35 Million Skr75.96 Million
Research & Development Skr15.46 Million Skr15.18 Million Skr26.50 Million Skr24.21 Million Skr22.49 Million
SG&A Skr41.28 Million Skr39.41 Million Skr38.72 Million Skr32.77 Million Skr40.74 Million
Total Operating Expenses Skr82.77 Million Skr79.92 Million Skr96.67 Million Skr78.60 Million Skr88.02 Million
Operating Income Skr-52.05 Million Skr-48.06 Million Skr-68.22 Million Skr-45.25 Million Skr-12.06 Million
EBITDA Skr-49.23 Million Skr-41.12 Million Skr-59.97 Million Skr-38.19 Million Skr-5.23 Million
EBIT Skr-51.43 Million Skr-47.63 Million Skr-67.75 Million Skr-44.81 Million Skr-12.26 Million
Interest Expense Skr1.91 Million Skr2.09 Million Skr997.00K Skr889.00K Skr804.00K
Income Before Tax Skr-53.34 Million Skr-49.72 Million Skr-68.75 Million Skr-45.70 Million Skr-13.06 Million
Income Tax Expense Skr-159.00K Skr9.00K Skr-89.00K Skr-307.00K Skr159.00K
Net Income Skr-53.18 Million Skr-49.73 Million Skr-68.66 Million Skr-45.39 Million Skr-13.22 Million

Enzymatica publ AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Enzymatica publ AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Skr195.22 Million Skr125.91 Million Skr174.41 Million Skr157.04 Million Skr162.03 Million
Total Current Assets Skr112.00 Million Skr38.78 Million Skr84.85 Million Skr64.78 Million Skr71.49 Million
Cash & Equivalents Skr75.21 Million Skr8.37 Million Skr50.69 Million Skr31.62 Million Skr24.02 Million
Short-term Investments — — — — —
Net Receivables Skr13.56 Million Skr12.48 Million Skr16.52 Million Skr18.83 Million Skr32.78 Million
Inventory Skr16.71 Million Skr11.50 Million Skr11.51 Million Skr12.44 Million Skr10.46 Million
Property, Plant & Equipment Skr14.40 Million Skr16.48 Million Skr16.40 Million Skr15.16 Million Skr10.26 Million
Goodwill Skr63.21 Million Skr63.21 Million Skr63.21 Million Skr63.21 Million Skr63.21 Million
Total Liabilities Skr18.86 Million Skr49.30 Million Skr48.12 Million Skr32.07 Million Skr55.38 Million
Total Current Liabilities Skr17.83 Million Skr32.44 Million Skr27.00 Million Skr30.94 Million Skr53.29 Million
Long-term Debt Skr0.00 Skr14.85 Million Skr20.88 Million Skr0.00 Skr233.00K
Net Debt Skr-73.01 Million Skr9.71 Million Skr-28.37 Million Skr-29.02 Million Skr-9.55 Million
Total Stockholder Equity Skr176.37 Million Skr76.61 Million Skr126.29 Million Skr124.97 Million Skr106.65 Million
Retained Earnings Skr-490.55 Million Skr-437.37 Million Skr-387.64 Million Skr-318.99 Million Skr-273.60 Million

Enzymatica publ AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Enzymatica publ AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Skr-60.51 Million Skr-40.29 Million Skr-64.57 Million Skr-35.87 Million Skr-10.65 Million
Capital Expenditures Skr393.00K Skr730.00K Skr3.72 Million Skr6.13 Million Skr4.84 Million
Free Cash Flow Skr-60.90 Million Skr-41.02 Million Skr-68.28 Million Skr-42.00 Million Skr-15.49 Million
Investing Cash Flow Skr-393.00K Skr-730.00K Skr-3.72 Million Skr-6.13 Million Skr-4.84 Million
Financing Cash Flow Skr127.65 Million Skr-1.39 Million Skr87.37 Million Skr49.53 Million Skr10.02 Million
Dividends Paid — — — — —
Stock-Based Compensation — — — — Skr739.00K
Depreciation Skr5.81 Million Skr6.51 Million Skr7.78 Million Skr6.63 Million Skr7.03 Million
Change in Cash Skr66.85 Million Skr-42.32 Million Skr19.07 Million Skr7.60 Million Skr-5.30 Million

Enzymatica publ AB Earnings History — EPS Actual vs. Analyst Estimates

Track Enzymatica publ AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 27, 2026 — — —
Feb 16, 2026 — — —
Oct 30, 2025 -0.03 — —
Jul 27, 2025 -0.06 — —
Apr 29, 2025 -0.07 — —
Feb 18, 2025 -0.05 — —
Nov 07, 2024 -0.04 — —
Jul 18, 2024 -0.08 — —